-
Registry data address major gaps in rare eye cancer
Eye experts at Flinders University have released new global findings that reveal how a rare eye cancer first appears, offering... Read more -
Belzutifan+pembrolizumab post-surgery helps kidney cancer patients at high risk for relapse stay cancer-free longer
Patients with a common form of kidney cancer called clear cell renal cell carcinoma (ccRCC) who have a high risk... Read more -
What is a 'cancer gene'? How genetic mutations lead to cancer
An estimated 170,000 Australians were diagnosed with cancer in 2025. Many people know the causes of cancer are partly genetic.... Read more -
Study reveals urgent need for dental coverage reform for oral cancer patients
Older Americans with oropharyngeal and oral cancers face high medical costs but are missing out on needed dental care, according... Read more -
Twenty years cancer-free: One man's story illustrates progress against follicular lymphoma
Twenty years. That's how long Robert Oman has been cancer-free, thanks to a clinical trial offered at the University of... Read more -
Blood test predicts which bladder cancer patients may safely skip surgery
Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for muscle-invasive bladder cancer, but... Read more -
Perioperative enfortumab vedotin + pembrolizumab tied to improved outcomes with bladder cancer
Perioperative enfortumab vedotin plus pembrolizumab and surgery lead to significantly better outcomes among patients with muscle-invasive bladder cancer who are... Read more -
Three-drug combo targets immune suppression to overcome melanoma resistance
For patients with advanced melanoma without BRAF mutation who no longer respond to immune checkpoint inhibitors, treatment options remain frustratingly... Read more -
PFAS exposure may alter lipid and hormone metabolism in testicular tumor cells
Cancer Center at Illinois (CCIL) members Ratnakar Singh and Michael Spinella collaborated in new research that fills in critical gaps... Read more -
What's the link between talcum powder and cancer?
More than 1,300 Victorians have joined a class action against Johnson & Johnson alleging its talcum powder products left them... Read more -
Pancreatic cancer may begin hiding from the immune system earlier than we thought
A new study from researchers at the Hebrew University of Jerusalem provides fresh insight into how pancreatic cancer may begin... Read more -
Largest study of vegetarian diets and cancer shows lower risk of five cancers
The largest ever study of non-meat diets and cancer risk has found that vegetarian diets are associated with lower risks... Read more -
A potential immunotherapy strategy for early-stage prostate cancer
Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically "cold," meaning they do not attract... Read more -
Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery, study finds
A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy... Read more -
There is more than one way for triple-negative breast cancer to become resistant to therapy
About 50% of triple-negative breast cancer (TNBC) patients develop resistance to therapy. When resistance arises, tumors are more likely to... Read more
